(Q24655188)

ORCID Public Data File 2021

author name string

Victoria Hellberg

1

0 references

Inger Wallin

2

0 references

Sofi Eriksson

3

0 references

Emma Hernlund

4

0 references

Elin Jerremalm

5

0 references

Maria Berndtsson

6

0 references

Elias S J Arnér

8

0 references

Maria Shoshan

9

0 references

Hans Ehrsson

10

0 references

Göran Laurell

Journal of the National Cancer Institute

11

0 references

language of work or name

English

0 references

publication date

7 January 2009

0 references

published in

0 references

volume

101

0 references

issue

1

0 references

page(s)

37-47

0 references

cites work

Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Reactive oxygen species, antioxidants, and the mammalian thioredoxin system

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Physiological functions of thioredoxin and thioredoxin reductase

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Thioredoxin and related molecules--from biology to health and disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Mechanisms of cisplatin-induced ototoxicity and prevention

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

The thioredoxin system in cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Molecular mechanisms of resistance and toxicity associated with platinating agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

On the potential of thioredoxin reductase inhibitors for cancer therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

DNA damage-induced cell death by apoptosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Altered expression of thioredoxin reductase-1 in dysplastic bile ducts and cholangiocarcinoma in a hamster model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

The development of platinum compounds and their possible combination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Local inner-ear drug delivery and pharmacokinetics.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

The thioredoxin system—From science to clinic

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Pharmacokinetics of oxaliplatin in humans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

A novel high-through-put assay for screening of pro-apoptotic drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Oxaliplatin: a review of evolving concepts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Calcium-dependent oxidation of thioredoxin during cellular growth initiation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Human thioredoxin reductase is efficiently inhibited by (2,2':6',2' '-terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling

30 May 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN418

Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN418

Liquid chromatographic determination of oxaliplatin in blood using post-column derivatization in a microwave field followed by photometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN418

Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN418

Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN418

Identification of a Zn2+-binding site on the dopamine D2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN418

The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN418

Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN418

Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639295

Estimation of variance for AUC in animal studies

28 November 2018

1 reference

12 December 2020

Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig

1 reference

12 December 2020

Pharmacokinetics of cisplatin and its monohydrated complex in humans

1 reference

12 December 2020

Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats

1 reference

12 December 2020

Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.

1 reference

12 December 2020

Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration

1 reference

12 December 2020

Apoptotic death of hair cells in mammalian vestibular sensory epithelia

1 reference

12 December 2020